Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Vasalgel
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
NEXT Life Sciences Announces Launch of Plan A™ Birth Control for Men
Details : Plan A™ (vasalgel) a hydrogel technology, which is in preclinical stage of developement, it is designed to give men birth control that is long-lasting, non-hormonal, and reversible on-demand.
Brand Name : Plan A
Molecule Type : Large molecule
Upfront Cash : Not Applicable
March 22, 2023
Lead Product(s) : Vasalgel
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?